Drug-Eluting Balloon Catheters Market
According to Intent Market Research, the Drug-Eluting Balloon Catheters Market is expected to grow from USD 2.3 billion in 2023 at a CAGR of 16.4% to touch USD 6.7 billion by 2030. The Drug-Eluting Balloon Catheters Market is dominated by key players such as Boston Scientific Corporation, Medtronic PLC, Abbott Laboratories, Terumo Corporation, Cordis (a Cardinal Health Company), Cook Medical, B. Braun Melsungen AG, Cardiovascular Systems, Inc., Asahi Intecc Co., Ltd., Strata Medical, Spectranetics (acquired by Philips), MicroPort Scientific Corporation, EndoSpan Ltd.